GI
PRVL

GAMCO Investors’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

GAMCO Investors’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-28,500
Closed -$657K – 951
2020
Q4 		$657K Buy
+28,500
New +$657K 0.01% 681